Horizon Therapeutics Plc (HZNP) – Strategy, SWOT and Corporate Finance Report
- Pages: 64
- Published: April 2023
- Report Code: MLPH243700FSA
Horizon Therapeutics Plc (HZNP) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Horizon Therapeutics Plc (Horizon Therapeutics) formerly Horizon Pharma plc, is a pharmaceutical company, which develops and commercializes medical products for the treatment of rare, autoimmune, arthritis and severe inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. A few of the company’s marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Pennsaid, Procysbi, Quinsair, Ravicti, Rayos, Uplinza, Tepezza and Vimovo. Horizon Therapeutics provides products and services to patients and healthcare professionals in the US. The company operates through offices in the US, Switzerland, Luxembourg, Bermuda, Germany, Canada, and Israel. Horizon Therapeutics is headquartered in Dublin, Ireland.
Scope
• Detailed information on Horizon Therapeutics Plc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Horizon Therapeutics Plc in the form of a SWOT analysis
• An in-depth view of the business model of Horizon Therapeutics Plc including a breakdown and examination of key business segments
• News about Horizon Therapeutics Plc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Horizon Therapeutics Plc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Horizon Therapeutics Plc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Horizon Therapeutics Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Acorda Therapeutics Inc
Sucampo Pharmaceuticals Inc
Option Care Health Inc
Arena Pharmaceuticals Inc
Aeglea BioTherapeutics Inc
Acorda Therapeutics Inc
Option Care Health Inc
Sucampo Pharmaceuticals Inc
Arena Pharmaceuticals Inc
Aeglea BioTherapeutics Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.